Department of Justice May 2005 – Federal Register Recent Federal Regulation Documents

Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-10728
Type: Notice
Date: 2005-05-31
Agency: Executive Office for Immigration Review, Department of Justice
Identification Markings Placed on Imported Explosive Materials and Miscellaneous Amendments (2000R-238P)
Document Number: 05-10618
Type: Rule
Date: 2005-05-27
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives, Alcohol, Tobacco, Firearms, and Explosives Bureau
The Department of Justice is amending the current regulations of the Bureau of Alcohol, Tobacco, Firearms, and Explosives (ATF) to require licensed importers to identify by marking all explosive materials they import for sale or distribution. Licensed manufacturers currently are required to place identification markings on explosive materials manufactured in the United States. Similar marking requirements, however, do not currently exist for imported explosive materials. Identification markings are needed on explosives to help ensure that these materials can be effectively traced for criminal enforcement purposes. Although ATF does not have regulatory oversight over foreign manufacturers, it does have authority over licensed importers of explosive materials. This rule will impose identification requirements on licensed importers of explosive materials that are substantially similar to the marking requirements imposed on domestic manufacturers. In addition, the final rule incorporates into the regulations the provisions of ATF Ruling 75-35, relating to methods of marking containers of explosive materials. This final rule also amends the regulations to remove the requirement that a licensee or permittee file for an amended license or permit in order to change the class of explosive materials described in their license or permit from a lower to a higher classification.
Inspection of Records Relating to Depiction of Sexually Explicit Performances
Document Number: 05-10107
Type: Rule
Date: 2005-05-24
Agency: Department of Justice
This rule amends the record-keeping and inspection requirements of 28 CFR part 75 to bring the regulations up to date with current law, to improve understanding of the regulatory system, and to make the inspection process effective for the purposes set by Congress in enacting the Child Protection and Obscenity Enforcement Act of 1988, as amended, relating to the sexual exploitation and other abuse of children.
Advisory Board Meeting
Document Number: 05-10204
Type: Notice
Date: 2005-05-23
Agency: Department of Justice, National Institute of Corrections
Clarifying of Release Gratuities-Release Transportation Regulations to More Closely Conform to Statutory Provisions
Document Number: 05-10045
Type: Rule
Date: 2005-05-20
Agency: Department of Justice, Bureau of Prisons, Prisons Bureau
This document finalizes an interim rule which made a minor clarifying change to the Bureau of Prisons (Bureau) regulations on release gratuities, transportation, and clothing. The rule clarified that the Bureau is authorized, upon an inmate's release, to provide transportation to an inmate's place of conviction or his/her legal residence only within the United States, under 18 U.S.C. 3624(d)(3).
Over-The-Counter (OTC) Medications: Technical Correction
Document Number: 05-10044
Type: Rule
Date: 2005-05-20
Agency: Department of Justice, Bureau of Prisons, Prisons Bureau
This document finalizes a minor technical correction to the Bureau of Prisons (Bureau) regulations on Over-The-Counter (OTC) medications. Previously, our rule defined an inmate without funds as one who has had an average daily trust fund account balance of less than $6.00 for the past 30 days. The words ``average daily'' in that definition resulted in incorrect classifications by the Bureau's business offices. The more accurate definition of an inmate without funds is one who has not had a trust fund account balance of $6.00 for the past 30 days. We therefore issue this technical correction.
Bureau of Prisons Emergencies
Document Number: 05-10043
Type: Rule
Date: 2005-05-20
Agency: Department of Justice, Bureau of Prisons, Prisons Bureau
The Bureau of Prisons (Bureau) makes this final rule to clarify that, when there is an institutional or system-wide Bureau emergency which the Director or designee considers a threat to human life or safety, the Director or designee may suspend the operation of the rules in this chapter as necessary to handle the emergency. This rule clarifies that the Director may suspend Bureau rules as needed in light of any emergency affecting the Bureau, and the Warden may do so to deal with emergencies at the institution level. This rule change clarifying the Director's authority to modify Bureau rules to handle emergencies is especially necessary in light of the recent terrorist attacks, threats to national security, threats of anthrax surrounding mail processing, and other events occurring on and after September 11, 2001.
Infectious Disease Management: Voluntary and Involuntary Testing
Document Number: 05-10042
Type: Rule
Date: 2005-05-20
Agency: Department of Justice, Bureau of Prisons, Prisons Bureau
In this document, the Bureau of Prisons (Bureau) finalizes regulations on the management of infectious diseases. The changes address the circumstances under which the Bureau conducts voluntary and involuntary testing for HIV, tuberculosis, and other infectious diseases. We intend this amendment to provide for the health and safety of staff and inmates.
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-9969
Type: Notice
Date: 2005-05-19
Agency: Department of Justice, Office of Justice Programs, Justice Programs Office
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-9968
Type: Notice
Date: 2005-05-19
Agency: Department of Justice, Office of Justice Programs, Justice Programs Office
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-9967
Type: Notice
Date: 2005-05-19
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives, Alcohol, Tobacco, Firearms, and Explosives Bureau
Salvatore DeFrank, D.P.M. Revocation of Registration
Document Number: 05-9838
Type: Notice
Date: 2005-05-18
Agency: Drug Enforcement Administration, Department of Justice
Katarzyna Rygiel, M.D.; Revocation of Registration
Document Number: 05-9837
Type: Notice
Date: 2005-05-18
Agency: Drug Enforcement Administration, Department of Justice
Robert A. Burkich, M.D.; Revocation of Registration
Document Number: 05-9836
Type: Notice
Date: 2005-05-18
Agency: Drug Enforcement Administration, Department of Justice
Rebecca Sotelo Denial of Registration
Document Number: 05-9835
Type: Notice
Date: 2005-05-18
Agency: Drug Enforcement Administration, Department of Justice
Lance L. Gooberman, M.D.; Denial of Registration
Document Number: 05-9834
Type: Notice
Date: 2005-05-18
Agency: Drug Enforcement Administration, Department of Justice
A-1 Distribution Wholesale; Denial of Registration
Document Number: 05-9833
Type: Notice
Date: 2005-05-18
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-9806
Type: Notice
Date: 2005-05-17
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives, Alcohol, Tobacco, Firearms, and Explosives Bureau
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-9805
Type: Notice
Date: 2005-05-17
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives, Alcohol, Tobacco, Firearms, and Explosives Bureau
Schedules of Controlled Substances: Placement of Pregabalin into Schedule V
Document Number: 05-9634
Type: Proposed Rule
Date: 2005-05-13
Agency: Drug Enforcement Administration, Department of Justice
This proposed rule is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place the substance pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid], including its salts, and all products containing pregabalin into Schedule V of the Controlled Substances Act (CSA). This proposed action is based on a recommendation from the Acting Assistant Secretary for Health of the Department of Health and Human Services (DHHS) and on an evaluation of the relevant data by DEA. If finalized, this action will impose the regulatory controls and criminal sanctions applicable to Schedule V non-narcotics on those who handle pregabalin and products containing pregabalin.
Preventing the Accumulation of Surplus Controlled Substances at Long Term Care Facilities
Document Number: 05-9538
Type: Rule
Date: 2005-05-13
Agency: Department of Justice, Drug Enforcement Administration
DEA is amending its regulations to allow, where State laws permit, for retail pharmacy installation of automated dispensing systems at long term care facilities. Automated dispensing systems would allow dispensing of single dosage units and mitigate the problem of excess stocks and disposal.
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-9344
Type: Notice
Date: 2005-05-11
Agency: Department of Justice, Office of Justice Programs, Justice Programs Office
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-9343
Type: Notice
Date: 2005-05-11
Agency: Department of Justice, Office of Justice Programs, Justice Programs Office
Net Wholesale; Revocation of Registration
Document Number: 05-9282
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
Jay Enterprises of Spartanburg, Inc.; Denial of Registration
Document Number: 05-9252
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
ELK International, Inc., d.b.a. Tri-City Wholesale; Denial of Application
Document Number: 05-9251
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
James Marvin Goodrich, M.D. Revocation of Registration
Document Number: 05-9250
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
Michael J. Millette, M.D.; Revocation of Registration
Document Number: 05-9249
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
John S. Poulter, D.D.S; Revocation of Registration
Document Number: 05-9248
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
Jay D. Angeluzzi, M.D.; Revocation of Registration
Document Number: 05-9247
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
Stephen K. Jones, M.D.; Denial of Registration
Document Number: 05-9246
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
Thomas J. Mulhearn, III, M.D.; Revocation of Registration
Document Number: 05-9245
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.